Micro-pharmacokinetics: Quantifying local drug concentration at live cell membranes

Area of Science:

• Pharmacology
• Biophysics
• Cell Biology

Background:

• Pharmacological models often assume uniform ligand distribution.
• Drugs can interact with cell membranes, altering local concentrations.
• Previous work suggested ligand-phospholipid interactions affect binding kinetics.

Purpose of the Study:

• To directly quantify local ligand concentrations near cell membranes.
• To investigate the role of the cell membrane and β2-adrenoceptor in local ligand accumulation.
• To reassess drug binding affinity considering micro-environmental effects.

Main Methods:

• Utilized fluorescence correlation spectroscopy (FCS) to measure ligand concentration.
• Employed a fluorescent propranolol derivative (BODIPY630/650-PEG8-S-propranolol) for detection.
• Studied ligand distribution at various distances from single living cell membranes.

Main Results:

• Demonstrated significantly higher local BY-propranolol concentrations adjacent to the cell membrane compared to the bulk phase.
• Confirmed the influence of both the cell membrane and β2-adrenoceptor on local ligand accumulation.
• Indicated that the actual binding affinity of BY-propranolol may be lower than previously estimated.

Conclusions:

• Cell membranes create distinct micro-environments that alter local drug concentrations.
• Micro-pharmacokinetics are crucial for accurately determining ligand binding affinity to membrane proteins.
• Standard pharmacological assumptions may need revision to account for membrane interactions.